Janice Brown
Infectious Disease · Stanford, CANPI 1912084542
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,128 of the $16,136 with a category attached, or 69.0%. 3 manufacturers reported payments, led by Merck at 48.9% of the total. Reporting peaked in 2019 at $9,133 and has fallen 82.2% since, to $1,628 in 2022. Among infectious disease clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 16 payments — averaging $1008.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$8K
- Paratek Pharmaceuticals, Inc.$5K
- Octapharma USA, Inc.$4K
Across 128 payments — averaging $3900.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astellas Pharma Global Development$271K
- Merck$160K
- Takeda Pharmaceuticals U.S.A., Inc.$63K
- Shire North American Group Inc$6K
What the payments were for
- Consulting fees$11,12869%
- Speaking & faculty fees$3,50022%
- Travel & lodging$1,3058%
- Food & beverage$2031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 10 | $7,898 |
| Paratek Pharmaceuticals, Inc. | 5 | $4,738 |
| Octapharma USA, Inc. | 1 | $3,500 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUZYRA$4,661
- OCTAGAM IMMUNE GLOBULIN (HUMAN)$3,500
How this compares
$16,136 in reported general payments places this provider in the 90th percentile of 856 infectious disease providers in California.
Other infectious disease in Stanford
- Paul EckburgStanford$98K
- Michael HarbourStanford$89K
- Philip GrantStanford$27K
- Claire PomeroySacramento$2.6M
- Javeed SiddiquiRoseville$1.5M
- George SakoulasSan Diego$902K
- Arthur JengSylmar$766K
- James McKinnellTorrance$762K
- Jay GladsteinLos Angeles$657K
- Tulika SinghOrange$654K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.